Cargando…
Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder
INTRODUCTION: Individuals with idiopathic rapid eye movement sleep behavior disorder (iRBD) are at high risk for a clinical diagnosis of an α‐synucleinopathy (aSN). They could serve as a key population for disease‐modifying trials. Abnormal dopamine transporter (DAT) imaging is a strong candidate bi...
Autores principales: | Chahine, Lana M., Brumm, Michael C., Caspell‐Garcia, Chelsea, Oertel, Wolfgang, Mollenhauer, Brit, Amara, Amy, Fernandez‐Arcos, Ana, Tolosa, Eduardo, Simonet, Cristina, Hogl, Birgit, Videnovic, Aleksandar, Hutten, Samantha J., Tanner, Caroline, Weintraub, Daniel, Burghardt, Elliot, Coffey, Christopher, Cho, Hyunkeun R., Kieburtz, Karl, Poston, Kathleen L., Merchant, Kalpana, Galasko, Douglas, Foroud, Tatiana, Siderowf, Andrew, Marek, Kenneth, Simuni, Tanya, Iranzo, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818144/ https://www.ncbi.nlm.nih.gov/pubmed/33321002 http://dx.doi.org/10.1002/acn3.51269 |
Ejemplares similares
-
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
por: Brumm, Michael C., et al.
Publicado: (2023) -
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
por: Chahine, L. M., et al.
Publicado: (2019) -
Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
por: Weintraub, Daniel, et al.
Publicado: (2023) -
Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease
por: Mollenhauer, Brit, et al.
Publicado: (2019) -
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2022)